Full-Time

Senior Account Manager

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$110k - $182k/yr

San Francisco, CA, USA

Remote

Category
Sales & Account Management (1)
Required Skills
Quality Assurance (QA)
Salesforce
Requirements
  • Bachelor’s degree in Life Sciences or related field (advanced degree preferred)
  • 5+ years of experience in life science sales with a strong emphasis on clinical, or regulated environments (biopharma, CROs, clinical labs)
  • Demonstrated experience working within or selling into GxP-regulated environments (e.g., GLP, GMP, GCP) and familiarity with clinical validation requirements
  • Practical experience with antibody-based applications relevant to clinical workflows (e.g., immunohistochemistry, flow cytometry, ELISA, high content imaging)
  • Proven ability to sell complex products / scientific solutions
  • Strong understanding of drug development, translational research, and/or diagnostic laboratory processes
  • Proven ability to navigate complex stakeholder environments, including QA/QC and regulatory functions
  • Excellent communication, presentation, and organizational skills
  • Proficiency with CRM systems (e.g., Salesforce) and Microsoft Office tools
  • Demonstrated ability to achieve and exceed revenue targets
  • Ability to travel regularly within the assigned territory, with occasional domestic/international travel
Responsibilities
  • Drive revenue growth by strategically positioning CST’s portfolio within research use only, clinical, translational, and regulated laboratory environments, aligning solutions with customer compliance and validation requirements
  • Manage and expand current and new key accounts across biopharma, CROs, clinical labs, and diagnostic organizations, utilizing a consultative, solution-based approach tailored to regulated workflows
  • Develop and execute comprehensive account plans that incorporate regulatory considerations, validation needs, and clinical application requirements
  • Identify and engage key stakeholders including clinical scientists, QA/QC, regulatory affairs, and laboratory leadership to support product adoption and long-term partnerships
  • Accurately forecast sales and maintain pipeline visibility, ensuring alignment with regulated procurement cycles and project timelines
  • Drive cross-selling and upselling opportunities by introducing validated, compliance-ready solutions that support clinical and diagnostic use cases
  • Partner with internal stakeholders to develop proposals, pricing strategies, and contracts that align with regulated purchasing processes and documentation requirements
  • Build and maintain strategic relationships with clinical investigators, translational scientists, lab directors, QA/QC leaders, and regulatory stakeholders
  • Serve as a trusted advisor by providing insights into product validation, assay reproducibility, documentation standards, and compliance considerations (e.g., GxP, CLIA, CAP where applicable)
  • Support customers in navigating product selection for clinical and regulated applications, ensuring alignment with their internal validation and quality standards
  • Deliver a high-quality customer experience by anticipating needs, ensuring timely responses, and maintaining consistent engagement across regulated environments
  • Collaborate with internal technical experts to deliver application support, validation guidance, and training tailored to clinical workflows
  • Partner closely with Sales, Product Management, Marketing, R&D, Quality, Regulatory, Legal, and Finance teams to support compliant commercialization and customer engagement strategies
  • Act as the voice of the customer, providing insights related to clinical use cases, regulatory expectations, and quality requirements to inform product development and positioning
  • Coordinate with technical and application scientists to ensure solutions meet validation standards and are fit-for-purpose in regulated settings
  • Facilitate alignment between global and regional teams on regulatory considerations, account strategies, and customer commitments
  • Monitor and analyze trends in clinical research, diagnostics, regulatory landscapes, and translational science, sharing insights to shape commercial and product strategies
  • Identify new opportunities in emerging clinical applications, companion diagnostics, and regulated research areas
  • Represent CST at industry conferences, clinical symposia, and regulatory-focused events to strengthen market presence and thought leadership
  • Provide input into portfolio and commercial strategy to ensure alignment with evolving clinical and regulatory requirements
  • Maintain accurate account records, contracts, and documentation in compliance with internal policies and external regulatory standards
  • Ensure all activities adhere to ethical sales practices, GxP expectations, and customer-specific compliance requirements
  • Support documentation needs related to product validation, audits, and regulated procurement processes where applicable
  • Manage expenses and reporting in accordance with company policies
  • Track and report performance metrics aligned with both commercial objectives and compliance expectations
Desired Qualifications
  • Master’s or Doctorate degree in Biology or related field including Cell Biology, Immunology, Molecular Biology
  • A doctorate degree is preferable
  • Existing network within the Bay Area biopharma and CRO ecosystem
  • Experience selling to both commercial biopharma and academic/government accounts
  • Familiarity with strategic selling methodologies and scientific collaborations
  • Demonstrated success in high-value solution and services selling
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Cell signaling market grows to $7.11 billion by 2030 at 7.3% CAGR.
  • Bio-Techne adds Simple Western validation to CST antibodies in 2023.
  • CST invests $17.5M in Manchester property in July 2022 for expansion.

What critics are saying

  • Leveragen nanobodies displace CST monoclonal antibodies in 12-24 months.
  • Lunaphore scales single B cell screening, eroding CST revenue in 12-18 months.
  • Visiopharm dependency fails if Indica Labs captures market in 18-36 months.

What makes Cell Signaling Technology unique

  • CST launches SignalStar Multiplex IHC for 8-plex amplification in two days.
  • CST partners with Visiopharm to integrate SignalStar with Phenoplex software.
  • CST expands chimeric monoclonal antibodies to mouse, horse, and feline species.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cell Signaling Technology who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Company News

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.

AZoNetwork
Sep 14th, 2023
Flexible Spatial Biology Solution for Up to 8-Plex Amplification in Two Days: CST Launches SignalStar™ Multiplex IHC

Cell Signaling Technology (CST) , a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.